Find clinical trials for Non-Small-Cell Lung Cancer in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Rochester, MN, USA:
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Rochester, Minnesota, United States and 83 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
Rochester, Minnesota, United States and 219 other locations
combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small c ...
Phase 1
Rochester, Minnesota, United States and 72 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Rochester, Minnesota, United States and 252 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Rochester, Minnesota, United States and 285 other locations
A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with ...
Phase 1
Rochester, Minnesota, United States and 22 other locations
This study will investigate the utility of biomarker-based triage for study participants with advanced non-small cell lung...
Phase 2
Rochester, Minnesota, United States and 80 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small...
Phase 1, Phase 2
Rochester, Minnesota, United States and 7 other locations
survival (OS) in treatment-naïve metastatic participants with non-small cell lung cancer (NSCLC)....
Phase 3
Rochester, Minnesota, United States and 148 other locations
This is an open-label, multi-center, dose-escalation study with expansion cohorts, designed to evaluate the safety and anti-tumor activity o-...
Phase 1
Rochester, Minnesota, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal